Breaking News Instant updates and real-time market news.

ANSS

Ansys

$214.29

4.1 (1.95%)

07:55
09/12/19
09/12
07:55
09/12/19
07:55

Ansys to host investor day

Investor day to be held in Pittsburgh, PA on September 12 at 8:30 am.

  • 12

    Sep

ANSS Ansys
$214.29

4.1 (1.95%)

07/11/19
WEDB
07/11/19
NO CHANGE
Target $228
WEDB
Outperform
Ansys price target raised to $228 from $221 at Wedbush
Wedbush analyst Steve Koenig raised his price target for Ansys to $228 from $221 as he expects the company's "sharp focus" on driving adoption at large accounts to drive 2019 upside, with double-digit growth on key metrics. The analyst likes Ansys' fundamentals, including its sustainable growth trend, strong margin profile, and market leadership in engineering simulation, and sees valuation as attractive. Koenig reiterates an Outperform rating on the shares.
07/22/19
SBSH
07/22/19
INITIATION
SBSH
Buy
Ansys initiated with a Buy at Citi
07/22/19
SBSH
07/22/19
INITIATION
Target $250
SBSH
Buy
Ansys initiated with a Buy at Citi
Citi analyst Tyler Radke started Ansys with a Buy rating and $250 price target. The analyst likes the shares as a "non-consensus idea." The company's execution improvements and "upstream" simulation opportunity are being underestimated by the market, while an eventual subscription transition is a "long-term call option," Radke tells investors in a research note.
09/11/19
JPMS
09/11/19
UPGRADE
Target $228
JPMS
Neutral
Ansys assumed with a Neutral from Underweight at JPMorgan
JPMorgan analyst Jackson Ader assumed coverage of Ansys and upgraded the shares to Neutral from Underweight with a price target of $228, raised from $190. The analyst sees Ansys as the most defensive name in the cyclical Simulation and Optimization Software sector, with its "industry diversity" and a 40%-plus margin profile "providing flexibility in a down market." However, the shares are currently trading at 35 times estimated 2020 free cash flow, "well beyond" the industry average of 22 times over the last 10 years, Ader tells investors in a research note.

TODAY'S FREE FLY STORIES

KNX

Knight-Swift

$35.68

-0.365 (-1.01%)

06:31
10/16/19
10/16
06:31
10/16/19
06:31
Recommendations
Knight-Swift analyst commentary  »

Knight-Swift should rally…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

ALXN

Alexion

$104.85

3.455 (3.41%)

, ACHN

Achillion

$3.66

0.115 (3.25%)

06:31
10/16/19
10/16
06:31
10/16/19
06:31
Hot Stocks
Breaking Hot Stocks news story on Alexion, Achillion »

Alexion to acquire…

ALXN

Alexion

$104.85

3.455 (3.41%)

ACHN

Achillion

$3.66

0.115 (3.25%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 23

    Oct

AMZN

Amazon.com

$1,768.70

31.65 (1.82%)

, ORCL

Oracle

$56.35

-0.1 (-0.18%)

06:29
10/16/19
10/16
06:29
10/16/19
06:29
Hot Stocks
Amazon says consumer business turns off final Oracle database »

Amazon (AMZN) said in a…

AMZN

Amazon.com

$1,768.70

31.65 (1.82%)

ORCL

Oracle

$56.35

-0.1 (-0.18%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 27

    Oct

  • 29

    Oct

  • 21

    Nov

BTI

British American Tobacco

$34.60

0.245 (0.71%)

, MO

Altria Group

$43.43

0.72 (1.69%)

06:27
10/16/19
10/16
06:27
10/16/19
06:27
Periodicals
Congress probes whether e-cig manufacturers paid for spam bots, WSJ reports »

Congress has launched an…

BTI

British American Tobacco

$34.60

0.245 (0.71%)

MO

Altria Group

$43.43

0.72 (1.69%)

IMBBY

Imperial Brands

$0.00

(0.00%)

PM

Philip Morris

$78.32

0.28 (0.36%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 12

    Nov

RYAM

Rayonier Advanced Materials

$4.70

0.21 (4.68%)

06:27
10/16/19
10/16
06:27
10/16/19
06:27
Downgrade
Rayonier Advanced Materials rating change  »

Rayonier Advanced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CP

Canadian Pacific

$218.42

3.27 (1.52%)

06:26
10/16/19
10/16
06:26
10/16/19
06:26
Downgrade
Canadian Pacific rating change  »

Canadian Pacific…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 13

    Nov

RYTM

Rhythm Pharmaceuticals

$20.90

0.52 (2.55%)

06:24
10/16/19
10/16
06:24
10/16/19
06:24
Syndicate
Rhythm Pharmaceuticals 8.11M share Spot Secondary priced at $18.50 »

The deal priced inside…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

PRQR

ProQR Therapeutics

$6.21

-0.09 (-1.43%)

06:23
10/16/19
10/16
06:23
10/16/19
06:23
Syndicate
ProQR Therapeutics 9.091M share Spot Secondary priced at $5.50 »

Citi and Evercore ISI…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

SSNLF

Samsung

$0.00

(0.00%)

06:23
10/16/19
10/16
06:23
10/16/19
06:23
Periodicals
Samsung places further EUV equipment orders, DigiTimes reports »

Samsung Electronics has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Oct

RYTM

Rhythm Pharmaceuticals

$20.90

0.52 (2.55%)

06:23
10/16/19
10/16
06:23
10/16/19
06:23
Syndicate
Rhythm Pharmaceuticals 8.108M share Spot Secondary priced at $18.50 »

The deal range was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

PRNB

Principia Biopharma

$29.88

0.7 (2.40%)

06:22
10/16/19
10/16
06:22
10/16/19
06:22
Syndicate
Principia Biopharma 7.5M share Spot Secondary priced at $28.00 »

The deal priced inside…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

EURN

Euronav NV

$10.72

-0.605 (-5.34%)

06:21
10/16/19
10/16
06:21
10/16/19
06:21
Recommendations
Euronav NV analyst commentary  »

Euronav a good play on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

BA

Boeing

$370.99

-2.05 (-0.55%)

, EADSY

Airbus

$0.00

(0.00%)

06:20
10/16/19
10/16
06:20
10/16/19
06:20
Periodicals
Entry date for Boeing's 777-8 depending on customer demand, Reuters reports »

The date of entry into…

BA

Boeing

$370.99

-2.05 (-0.55%)

EADSY

Airbus

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

XOG

Extraction Oil & Gas

$2.65

-0.05 (-1.85%)

06:19
10/16/19
10/16
06:19
10/16/19
06:19
Downgrade
Extraction Oil & Gas rating change  »

Extraction Oil & Gas…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Nov

CNI

Canadian National

$86.78

0.38 (0.44%)

06:19
10/16/19
10/16
06:19
10/16/19
06:19
Upgrade
Canadian National rating change  »

Canadian National…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 13

    Nov

  • 21

    Nov

  • 22

    Nov

INOV

Inovalon

$15.04

0.2 (1.35%)

06:19
10/16/19
10/16
06:19
10/16/19
06:19
Initiation
Inovalon initiated  »

Citi starts Inovalon with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WAB

Wabtec

$67.83

1.185 (1.78%)

06:17
10/16/19
10/16
06:17
10/16/19
06:17
Initiation
Wabtec initiated  »

Wabtec initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Oct

  • 13

    Nov

ADBE

Adobe

$279.40

1.61 (0.58%)

06:15
10/16/19
10/16
06:15
10/16/19
06:15
Downgrade
Adobe rating change  »

Citi downgrades Adobe to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 27

    Oct

  • 29

    Oct

  • 04

    Nov

PLMR

Palomar

$40.61

-0.26 (-0.64%)

06:13
10/16/19
10/16
06:13
10/16/19
06:13
Initiation
Palomar initiated  »

Palomar initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AXSM

Axsome Therapeutics

$20.65

2.42 (13.27%)

06:12
10/16/19
10/16
06:12
10/16/19
06:12
Initiation
Axsome Therapeutics initiated  »

Axsome Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SNBR

Sleep Number

$46.69

0.48 (1.04%)

06:11
10/16/19
10/16
06:11
10/16/19
06:11
Recommendations
Sleep Number analyst commentary  »

Sleep Number price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CNI

Canadian National

$86.78

0.38 (0.44%)

06:11
10/16/19
10/16
06:11
10/16/19
06:11
Upgrade
Canadian National rating change  »

Canadian National…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 13

    Nov

  • 21

    Nov

  • 22

    Nov

PLMR

Palomar

$40.61

-0.26 (-0.64%)

06:10
10/16/19
10/16
06:10
10/16/19
06:10
Initiation
Palomar initiated  »

Palomar initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CP

Canadian Pacific

$218.42

3.27 (1.52%)

06:08
10/16/19
10/16
06:08
10/16/19
06:08
Downgrade
Canadian Pacific rating change  »

Canadian Pacific…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 13

    Nov

MCK

McKesson

$138.17

4.01 (2.99%)

, ABC

AmerisourceBergen

$83.18

1.6 (1.96%)

06:08
10/16/19
10/16
06:08
10/16/19
06:08
Recommendations
McKesson, AmerisourceBergen, Cardinal Health analyst commentary  »

Barclays ups McKesson…

MCK

McKesson

$138.17

4.01 (2.99%)

ABC

AmerisourceBergen

$83.18

1.6 (1.96%)

CAH

Cardinal Health

$47.93

1.16 (2.48%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 30

    Oct

  • 06

    Nov

  • 07

    Nov

  • 07

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.